retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric First Retatrutide phase 3 data,

What Consumers Should Know About GLP-1 Evidence and FeelGood's Brand-Stated Outcome Claims There are two separate issues consumers should not confuse: the clinical evidence for FDA-approved GLP-1 medications in appropriate patients, and FeelGood's brand-stated outcome claims for its own telehealth program

We understand the nuances of managing medications like Zepbound, and our team is always ready to address your concerns, from storage during travel to adjusting your dosage schedule across time zones

Many adults across California are seeking medically guided programs that offer professional oversight without requiring frequent in-person visits

Available In-Clinic & Mobile $229-$428 The Executive includes Magnesium along with a targeted B complex designed to support focus and calm, steady energy during busy periods